세계의 화상 치료 시장(-2030년) : 제품(첨단 드레싱재(콜라겐, 필름, 하이드로겔, 폼, 알긴산염 드레싱), 치료 기기(데브리드만, NPWT), 생물학적 치료, 기존 치료), 화상도(1도 화상, 2도 화상, 3도 화상), 최종사용자(병원, ASC)

The burn care market is expected to grow from USD 2.55 billion in 2025 to USD 3.35 billion by 2030, at a CAGR of 5.6%. The increasing global incidence of burn injuries has driven the demand for effective treatment technologies, contributing to market growth. Advancements in burn care technology, heightened awareness of the importance of early intervention, and supportive government initiatives are also facilitating this growth.

"The advanced burn dressings segment accounted for the largest share of the burn care market in 2024."

Based on products, the burn care market is divided into several segments: advanced burn dressings, burn wound therapy devices, biologics, traditional burn care products, and other burn care products. Among these, the advanced burn dressings segment holds the largest market share. This dominance is attributed to their significant therapeutic benefits, such as the ability to maintain a moist wound environment, reduce the risk of infection, and accelerate the healing process. Furthermore, ongoing advancements in dressing materials and designs consistently enhance their effectiveness and solidify their position in the burn care market.

"The hospitals segment is expected to register the highest growth in the burn care market, by end user, during the forecast period."

Based on end users, the burn care market is divided into several segments: hospitals, physician clinics & ambulatory care settings, home care settings, burn treatment centers, and other end users. The hospitals segment is expected to show the highest growth rate during the forecast period. This growth can be attributed to increased burn admissions, specialized burn units, and the availability of skilled healthcare professionals and advanced treatment facilities in hospitals.

"Asia Pacific is expected to be the fastest-growing regional segment in the burn care market."

The global burn care market is divided into several regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these, the Asia Pacific region is expected to experience the highest CAGR in the burn care market. This growth is driven by a rise in the incidence of burn injuries, increased healthcare spending, a greater use of advanced treatment products, and improved awareness of burn management in developing economies within the region.

Break-up of the profile of primary participants in the burn care market:

• By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
• By Designation: C-level Executives (27%), Director-level Executives (18%), and Others (55%)
• By Region: North America (51%), Europe (21%), Asia Pacific (18%), Latin America (6%), and the Middle East & Africa (4%)

The key players in the market are Smith+Nephew (UK), Molnlycke Health Care AB (Sweden), Cardinal Health Inc. (US), Integra LifeSciences Holdings Corporation (US), ConvaTec Group Plc (UK), Coloplast Group (Denmark), Solventum Corporation (US), B. Braun SE (Germany), Essity Aktiebolag (Sweden), PAUL HARTMANN AG (Germany), Mativ Holdings, Inc. (US), Advanced Medical Solutions Group Plc (UK), Organogenesis Holdings Inc. (US), Vericel Corporation (US), MiMedx Group, Inc. (US), DeRoyal Industries. Inc. (US), Lohmann & Rauscher International GmbH & Co. KG (Germany), Moor Instruments Limited (UK), Medline Industries, LP (US), Urgo Group (France), MISSNER & MISSNER LTDA (Brazil), MIMOSA Diagnostics (Canada), DermaRite Industries, LLC (US), Focus Health Group (US), Axio Biosolutions Pvt. Ltd. (India), Mil Laboratories Pvt. Ltd. (India), and Hubei Hendry Medical Appliance Co., Ltd. (China).

Research Coverage:

This research report categorizes the burn care market by product (advanced burn dressings, burn wound therapy devices, biologics, traditional burn care products, and other burn care products), burn degree [first-degree burns (minor burns), second-degree burns (partial-thickness burns), and third-degree burns (full-thickness burns)], end user (hospitals, physician clinics & ambulatory care settings, home care settings, burn treatment centers, and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges, influencing the growth of the burn care market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. Recent developments and new product launches in the burn care market are discussed in this report, along with a competitive analysis of emerging startups within the burn care ecosystem.

Reasons to Buy this Report:

The report provides valuable information for both market leaders and new entrants in the burn care market. It offers approximate revenue figures for the overall market and its subsegments. Stakeholders can use this report to gain insights into the competitive landscape, which will aid them in positioning their businesses more effectively and developing appropriate go-to-market strategies. Additionally, the report highlights key market drivers, restraints, opportunities, and challenges, allowing stakeholders to better understand current market dynamics.

The report provides insights on the following pointers:

• Analysis of key drivers (rising incidence of burn injuries, advancements in burn care products, rising government and industry initiatives, growing use of regenerative medicine for wound management), opportunities (high growth opportunities in emerging economies), restraints (high cost of advanced burn care treatments and risks associated with the use of advanced burn care products), and challenges (availability of alternative therapies) influencing the growth of the burn care market.
• Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, and new product launches in the burn care market.
• Market Development: Detailed analysis of the burn care market across various regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the burn care market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Smith+Nephew (UK), Molnlycke Health Care AB (Sweden), Cardinal Health Inc. (US), Integra LifeSciences Holdings Corporation (US), and ConvaTec Group Plc (UK)

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 UNIT CONSIDERED
• 1.6 KEY STAKEHOLDERS
• 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key secondary sources
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY RESEARCH
    • 2.1.2.1 Key primary sources
    • 2.1.2.2 Key data from primary sources
    • 2.1.2.3 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Approach 1: Company revenue estimation approach
    • 2.2.1.2 Approach 2: Presentations of companies and primary interviews
    • 2.2.1.3 Growth forecast
    • 2.2.1.4 CAGR projections
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.4 MARKET SHARE ASSESSMENT
• 2.5 RESEARCH ASSUMPTIONS
  • 2.5.1 PARAMETRIC ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 BURN CARE MARKET OVERVIEW
• 4.2 BURN CARE MARKET, BY PRODUCT, 2025 VS. 2030
• 4.3 BURN CARE MARKET, BY BURN DEGREE, 2025 VS. 2030
• 4.4 BURN CARE MARKET, BY END USER, 2025 VS. 2030
• 4.5 BURN CARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising incidence of burn injuries
    • 5.2.1.2 Advancements in burn care products
    • 5.2.1.3 Rising government and industry initiatives
    • 5.2.1.4 Growing use of regenerative medicine for wound management
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of advanced burn care treatments
    • 5.2.2.2 Risks associated with use of advanced burn care products
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 High growth opportunities in emerging economies
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Availability of alternative therapies
• 5.3 PRICING ANALYSIS
  • 5.3.1 INDICATIVE SELLING PRICE TREND, BY PRODUCT
  • 5.3.2 INDICATIVE SELLING PRICE TREND OF ADVANCED BURN DRESSINGS, BY KEY PLAYER
  • 5.3.3 INDICATIVE SELLING PRICE TREND OF BURN CARE PRODUCTS, BY REGION
• 5.4 PATENT ANALYSIS
  • 5.4.1 LIST OF MAJOR PATENTS
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 SUPPLY CHAIN ANALYSIS
• 5.7 TRADE ANALYSIS
  • 5.7.1 IMPORT DATA (HS CODE 3005)
  • 5.7.2 EXPORT DATA (HS CODE 3005)
• 5.8 ECOSYSTEM ANALYSIS
  • 5.8.1 ROLE IN ECOSYSTEM
• 5.9 PORTER'S FIVE FORCES ANALYSIS
  • 5.9.1 THREAT OF NEW ENTRANTS
  • 5.9.2 THREAT OF SUBSTITUTES
  • 5.9.3 BARGAINING POWER OF BUYERS
  • 5.9.4 BARGAINING POWER OF SUPPLIERS
  • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.10 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.10.2 BUYING CRITERIA
• 5.11 REGULATORY ANALYSIS
  • 5.11.1 REGULATORY LANDSCAPE
    • 5.11.1.1 North America
      • 5.11.1.1.1 US
      • 5.11.1.1.2 Canada
    • 5.11.1.2 Europe
      • 5.11.1.2.1 Germany
      • 5.11.1.2.2 UK
      • 5.11.1.2.3 France
      • 5.11.1.2.4 Italy
    • 5.11.1.3 Asia Pacific
      • 5.11.1.3.1 China
      • 5.11.1.3.2 Japan
      • 5.11.1.3.3 India
    • 5.11.1.4 Latin America
    • 5.11.1.5 Middle East
      • 5.11.1.5.1 Africa
  • 5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.11.2.1 North America
    • 5.11.2.2 Europe
    • 5.11.2.3 Asia Pacific
    • 5.11.2.4 Latin America
    • 5.11.2.5 Rest of the World
• 5.12 TECHNOLOGY ANALYSIS
  • 5.12.1 KEY TECHNOLOGIES
    • 5.12.1.1 Negative-pressure wound therapy (NPWT)
  • 5.12.2 COMPLEMENTARY TECHNOLOGIES
    • 5.12.2.1 Burn wound assessment devices
  • 5.12.3 ADJACENT TECHNOLOGIES
    • 5.12.3.1 Debridement devices
• 5.13 KEY CONFERENCES & EVENTS, 2025-2026
• 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.15 INVESTMENT & FUNDING SCENARIO
• 5.16 CASE STUDY ANALYSIS
  • 5.16.1 CASE STUDY 1: MANAGEMENT OF LARGE SURFACE AREA BURNS WITH GRAFTS OF SELF-ALLOGENEIC SKIN
  • 5.16.2 CASE STUDY 2: EFFECTIVE MANAGEMENT OF SUPERFICIAL PARTIAL-THICKNESS BURNS USING ANTIMICROBIAL DRESSINGS
• 5.17 IMPACT OF AI ON BURN CARE MARKET
  • 5.17.1 INTRODUCTION
  • 5.17.2 MARKET POTENTIAL OF AI
  • 5.17.3 AI USE CASES
  • 5.17.4 KEY COMPANIES IMPLEMENTING AI
  • 5.17.5 FUTURE OF AI IN BURN CARE MARKET
• 5.18 US BURN CARE MARKET LANDSCAPE
  • 5.18.1 LENGTH OF STAY AND COST DRIVERS OF BURN TREATMENT
    • 5.18.1.1 Length of stay
    • 5.18.1.2 Cost drivers of burn treatment
  • 5.18.2 CPT AND DRG CODES FOR BURNS
  • 5.18.3 INSURANCE POLICIES & COVERAGE
  • 5.18.4 TREATMENT COST BY HOSPITALS
  • 5.18.5 REIMBURSEMENT SCENARIO IN US
    • 5.18.5.1 Changes in reimbursement scenario in US
• 5.19 TRUMP TARIFF IMPACT ON BURN CARE MARKET
  • 5.19.1 INTRODUCTION
  • 5.19.2 KEY TARIFF RATES

6 BURN CARE MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 ADVANCED BURN DRESSINGS
  • 6.2.1 ALGINATE DRESSINGS
    • 6.2.1.1 Ability to absorb exudates and promote faster healing to boost adoption
  • 6.2.2 COLLAGEN DRESSINGS
    • 6.2.2.1 Increasing regulatory approvals for collagen-based products in burn care to fuel growth
  • 6.2.3 HYDROGEL DRESSINGS
    • 6.2.3.1 Advancements in hydrogel dressings to drive market adoption by improving burn care efficiency
  • 6.2.4 HYDROCOLLOID DRESSINGS
    • 6.2.4.1 Ability to promote healing by providing protective barrier to burn wounds to drive market
  • 6.2.5 WOUND CONTACT LAYERS
    • 6.2.5.1 Ability to protect wound bed from bacterial growth while promoting healing to propel growth
  • 6.2.6 FILM DRESSINGS
    • 6.2.6.1 Non-absorbable nature of film dressings to limit adoption
  • 6.2.7 FOAM DRESSINGS
    • 6.2.7.1 High absorbency and ongoing advancements in antibacterial technology in foam dressings to contribute to growth
  • 6.2.8 OTHER ADVANCED BURN DRESSINGS
• 6.3 BURN WOUND THERAPY DEVICES
  • 6.3.1 BURN WOUND ASSESSMENT DEVICES
    • 6.3.1.1 Improved precision in burn evaluation and treatment planning to increase adoption
    • 6.3.1.2 Key players providing burn wound assessment devices
    • 6.3.1.3 AI and machine learning integration in burn wound assessment
    • 6.3.1.4 Core technologies in burn wound assessment
      • 6.3.1.4.1 Laser doppler imaging (LDI)
      • 6.3.1.4.2 Thermal imaging & fluorescence imaging
    • 6.3.1.5 Emerging innovations in burn wound assessment
  • 6.3.2 NPWT DEVICES
    • 6.3.2.1 Growing adoption of single-use NPWT devices in home care settings to drive market
  • 6.3.3 OTHER BURN WOUND THERAPY DEVICES
• 6.4 BIOLOGICS
  • 6.4.1 INCREASING ADOPTION OF INNOVATIVE SKIN GRAFTS FOR EFFECTIVE MANAGEMENT OF SEVERE BURN WOUNDS TO DRIVE MARKET GROWTH
• 6.5 TRADITIONAL BURN CARE PRODUCTS
  • 6.5.1 TAPES
    • 6.5.1.1 Increased use of tapes for burn wound coverage to fuel market growth
  • 6.5.2 DRESSINGS
    • 6.5.2.1 Widespread use of basic dry dressings in minor burns to fuel market growth
• 6.6 OTHER BURN CARE PRODUCTS

7 BURN CARE MARKET, BY BURN DEGREE

• 7.1 INTRODUCTION
• 7.2 SECOND-DEGREE BURNS (PARTIAL-THICKNESS BURNS)
  • 7.2.1 ENHANCED BURN CARE TECHNOLOGIES TO ACCELERATE HEALING OUTCOMES FOR PARTIAL-THICKNESS BURNS
• 7.3 FIRST-DEGREE BURNS (MINOR BURNS)
  • 7.3.1 HIGH PREVALENCE OF FIRST-DEGREE BURNS TO SIGNIFICANTLY CONTRIBUTE TO MARKET GROWTH
• 7.4 THIRD-DEGREE BURNS (FULL-THICKNESS BURNS)
  • 7.4.1 NEED FOR SPECIALIZED TREATMENTS FOR THIRD-DEGREE BURNS TO FUEL MARKET EXPANSION

8 BURN CARE MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 HOSPITALS
  • 8.2.1 INPATIENT FACILITIES
    • 8.2.1.1 Increasing number of hospital admissions to drive market growth
  • 8.2.2 OUTPATIENT FACILITIES
    • 8.2.2.1 Cost-efficiency of outpatient settings to boost market growth
• 8.3 PHYSICIAN CLINICS & AMBULATORY CARE SETTINGS
  • 8.3.1 LOWER COSTS AND SHORTER PATIENT STAYS TO PROPEL GROWTH
• 8.4 HOME CARE SETTINGS
  • 8.4.1 TECHNOLOGICAL INNOVATION AND INCREASED PRODUCT AVAILABILITY TO BOOST MARKET GROWTH
• 8.5 BURN TREATMENT CENTERS
  • 8.5.1 RISING BURN PATIENT NUMBERS TO FUEL GROWTH OF BURN TREATMENT CENTERS
• 8.6 OTHER END USERS

9 BURN CARE MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
  • 9.2.2 US
    • 9.2.2.1 Rising incidence of burns and continuous product innovation to propel market growth
  • 9.2.3 CANADA
    • 9.2.3.1 Increase in fire incidents to drive growth in burn care market in Canada
• 9.3 EUROPE
  • 9.3.1 EUROPE: MACROECONOMIC OUTLOOK
  • 9.3.2 UK
    • 9.3.2.1 Rising burn injuries and strong R&D investments to drive market growth
  • 9.3.3 GERMANY
    • 9.3.3.1 High healthcare expenditure and rising incidence of burn injuries to drive significant growth
  • 9.3.4 FRANCE
    • 9.3.4.1 Ongoing advancements in burn care technology to fuel market growth
  • 9.3.5 ITALY
    • 9.3.5.1 Improvements in quality and accessibility of medical care to drive market growth
  • 9.3.6 SPAIN
    • 9.3.6.1 Growing elderly population to boost demand for burn care products in Spain
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
  • 9.4.2 CHINA
    • 9.4.2.1 Growing elderly population and improved healthcare infrastructure to fuel market growth
  • 9.4.3 JAPAN
    • 9.4.3.1 Increasing regulatory approvals for burn care products to drive market growth
  • 9.4.4 INDIA
    • 9.4.4.1 High prevalence of burns and healthcare improvements to fuel market growth
  • 9.4.5 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 IMPROVED ACCESS TO HEALTHCARE TO DRIVE DEMAND FOR BURN CARE PRODUCTS
  • 9.5.2 LATIN AMERICA: MACROECONOMIC OUTLOOK
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 INCREASING HEALTHCARE INVESTMENTS TO SUPPORT MARKET GROWTH
  • 9.6.2 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BURN CARE MARKET
• 10.3 REVENUE ANALYSIS, 2022-2024
• 10.4 MARKET SHARE ANALYSIS, 2024
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Region footprint
    • 10.5.5.3 Product footprint
    • 10.5.5.4 Advanced burn care dressings footprint
    • 10.5.5.5 Burn degree footprint
• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 10.6.5.1 Detailed list of key startups/SMEs
    • 10.6.5.2 Competitive benchmarking of startups/SMEs
• 10.7 COMPANY VALUATION & FINANCIAL METRICS
• 10.8 BRAND/PRODUCT COMPARISON
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 PRODUCT LAUNCHES & APPROVALS
  • 10.9.2 DEALS
  • 10.9.3 EXPANSIONS
  • 10.9.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 SMITH+NEPHEW
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Product launches
      • 11.1.1.3.2 Deals
      • 11.1.1.3.3 Expansions
      • 11.1.1.3.4 Other developments
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Right to win
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses & competitive threats
  • 11.1.2 MOLNLYCKE HEALTH CARE AB
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Deals
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Right to win
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses & competitive threats
  • 11.1.3 CARDINAL HEALTH INC.
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Expansions
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Right to win
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses & competitive threats
  • 11.1.4 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Product launches
      • 11.1.4.3.2 Deals
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Right to win
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses & competitive threats
  • 11.1.5 CONVATEC GROUP PLC
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
    • 11.1.5.3 Recent developments
      • 11.1.5.3.1 Product approvals
      • 11.1.5.3.2 Deals
    • 11.1.5.4 MnM view
      • 11.1.5.4.1 Right to win
      • 11.1.5.4.2 Strategic choices
      • 11.1.5.4.3 Weaknesses & competitive threats
  • 11.1.6 COLOPLAST GROUP
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Deals
  • 11.1.7 SOLVENTUM CORPORATION
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Other developments
  • 11.1.8 B. BRAUN SE
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
  • 11.1.9 ESSITY AKTIEBOLAG
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
    • 11.1.9.3 Recent developments
      • 11.1.9.3.1 Deals
  • 11.1.10 PAUL HARTMANN AG
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
  • 11.1.11 MATIV HOLDINGS, INC.
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products offered
    • 11.1.11.3 Recent developments
      • 11.1.11.3.1 Deals
  • 11.1.12 ADVANCED MEDICAL SOLUTIONS GROUP PLC
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products offered
  • 11.1.13 ORGANOGENESIS HOLDINGS INC.
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products offered
  • 11.1.14 VERICEL CORPORATION
    • 11.1.14.1 Business overview
    • 11.1.14.2 Products offered
    • 11.1.14.3 Recent developments
      • 11.1.14.3.1 Product launches & approvals
  • 11.1.15 MIMEDX GROUP, INC.
    • 11.1.15.1 Business overview
    • 11.1.15.2 Products offered
    • 11.1.15.3 Recent developments
      • 11.1.15.3.1 Product launches
      • 11.1.15.3.2 Deals
• 11.2 OTHER PLAYERS
  • 11.2.1 DEROYAL INDUSTRIES, INC.
  • 11.2.2 LOHMANN & RAUSCHER GMBH & CO. KG
  • 11.2.3 MEDLINE INDUSTRIES, LP
  • 11.2.4 MOOR INSTRUMENTS LIMITED
  • 11.2.5 URGO GROUP
  • 11.2.6 MISSNER & MISSNER LTDA
  • 11.2.7 MIMOSA DIAGNOSTICS
  • 11.2.8 DERMARITE INDUSTRIES, LLC
  • 11.2.9 FOCUS HEALTH GROUP
  • 11.2.10 AXIO BIOSOLUTIONS PVT. LTD.
  • 11.2.11 MIL LABORATORIES PVT. LTD.
  • 11.2.12 HUBEI HENDRY MEDICAL APPLIANCE CO., LTD.

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS